{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:37:46Z","timestamp":1790739466622,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:00:00Z","timestamp":1372723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-324","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:14:56Z","timestamp":1372724096000},"source":"Crossref","is-referenced-by-count":40,"title":["Defect in recruiting effector memory CD8+T-cells in malignant pleural effusions compared to normal pleural fluid"],"prefix":"10.1186","volume":"13","author":[{"given":"Arnaud","family":"Scherpereel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan Dragos","family":"Grigoriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Noppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachar","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Baldacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Trauet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Copin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Dessaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labalette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,2]]},"reference":[{"key":"3978_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1201\/b14205-24","volume-title":"Pleural disease","author":"S Sahn","year":"2004","unstructured":"Sahn S: Malignant pleural effusions. Pleural disease. Edited by: Bouros D. 2004, London: Informa Healthcare, 411-438."},{"issue":"3","key":"3978_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, et al: Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010, 35 (3): 479-495. 10.1183\/09031936.00063109.","journal-title":"Eur Respir J"},{"issue":"2","key":"3978_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0169-5002(00)00217-8","volume":"32","author":"BW Robinson","year":"2001","unstructured":"Robinson BW, Robinson C, Lake RA: Localised spontaneous regression in mesothelioma \u2013 possible immunological mechanism. Lung Cancer. 2001, 32 (2): 197-201. 10.1016\/S0169-5002(00)00217-8.","journal-title":"Lung Cancer"},{"issue":"10","key":"3978_CR4","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2099::AID-CNCR8>3.0.CO;2-3","volume":"83","author":"P Astoul","year":"1998","unstructured":"Astoul P, et al: Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study. Cancer. 1998, 83 (10): 2099-2104. 10.1002\/(SICI)1097-0142(19981115)83:10<2099::AID-CNCR8>3.0.CO;2-3.","journal-title":"Cancer"},{"issue":"9","key":"3978_CR5","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/1097-0142(19941101)74:9<2460::AID-CNCR2820740912>3.0.CO;2-N","volume":"74","author":"C Boutin","year":"1994","unstructured":"Boutin C, et al: Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer. 1994, 74 (9): 2460-2467. 10.1002\/1097-0142(19941101)74:9<2460::AID-CNCR2820740912>3.0.CO;2-N.","journal-title":"Cancer"},{"issue":"2","key":"3978_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/CJI.0b013e318195b5bb","volume":"32","author":"M Sebastian","year":"2009","unstructured":"Sebastian M, et al: Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1\/2 study. J Immunother. 2009, 32 (2): 195-202. 10.1097\/CJI.0b013e318195b5bb.","journal-title":"J Immunother"},{"issue":"10","key":"3978_CR7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1164\/rccm.200501-057OC","volume":"171","author":"JP Hegmans","year":"2005","unstructured":"Hegmans JP, et al: Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells. Am J Respir Crit Care Med. 2005, 171 (10): 1168-1177. 10.1164\/rccm.200501-057OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"3978_CR8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1164\/rccm.200909-1465OC","volume":"181","author":"JP Hegmans","year":"2010","unstructured":"Hegmans JP, et al: Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma. Am J Respir Crit Care Med. 2010, 181 (12): 1383-1390. 10.1164\/rccm.200909-1465OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"3978_CR9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1164\/rccm.201103-0554CR","volume":"184","author":"DH Sterman","year":"2011","unstructured":"Sterman DH, et al: A trial of intrapleural adenoviral-mediated Interferon-alpha2b gene transfer for malignant pleural mesothelioma. Am J Respir Crit Care Med. 2011, 184 (12): 1395-1399. 10.1164\/rccm.201103-0554CR.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3978_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1586\/ers.10.33","volume":"4","author":"M Gregoire","year":"2010","unstructured":"Gregoire M: Dendritic cell vaccination as a treatment modality for mesothelioma. Expert Rev Respir Med. 2010, 4 (3): 311-314. 10.1586\/ers.10.33.","journal-title":"Expert Rev Respir Med"},{"issue":"12","key":"3978_CR11","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.4049\/jimmunol.151.12.7216","volume":"151","author":"VB Antony","year":"1993","unstructured":"Antony VB, et al: Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol. 1993, 151 (12): 7216-7223.","journal-title":"J Immunol"},{"issue":"8","key":"3978_CR12","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/eji.200939722","volume":"39","author":"F Sallusto","year":"2009","unstructured":"Sallusto F, Lanzavecchia A: Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol. 2009, 39 (8): 2076-2082. 10.1002\/eji.200939722.","journal-title":"Eur J Immunol"},{"issue":"6754","key":"3978_CR13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, et al: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999, 401 (6754): 708-712. 10.1038\/44385.","journal-title":"Nature"},{"issue":"3","key":"3978_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ni889","volume":"4","author":"EJ Wherry","year":"2003","unstructured":"Wherry EJ, et al: Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol. 2003, 4 (3): 225-234.","journal-title":"Nat Immunol"},{"issue":"2","key":"3978_CR15","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.4049\/jimmunol.174.2.1037","volume":"174","author":"A Harari","year":"2005","unstructured":"Harari A, et al: Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol. 2005, 174 (2): 1037-1045.","journal-title":"J Immunol"},{"issue":"11","key":"3978_CR16","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.4049\/jimmunol.172.11.6533","volume":"172","author":"AD Roberts","year":"2004","unstructured":"Roberts AD, Woodland DL: Cutting edge: effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung. J Immunol. 2004, 172 (11): 6533-6537.","journal-title":"J Immunol"},{"key":"3978_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","volume":"211","author":"CA Klebanoff","year":"2006","unstructured":"Klebanoff CA, Gattinoni L, Restifo NP: CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev. 2006, 211: 214-224. 10.1111\/j.0105-2896.2006.00391.x.","journal-title":"Immunol Rev"},{"issue":"6","key":"3978_CR18","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1378\/chest.128.6.4030","volume":"128","author":"M Okamoto","year":"2005","unstructured":"Okamoto M, et al: T-helper type 1\/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Chest. 2005, 128 (6): 4030-4035. 10.1378\/chest.128.6.4030.","journal-title":"Chest"},{"issue":"5","key":"3978_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1590\/S1807-59322008000500012","volume":"63","author":"LM Aguiar","year":"2008","unstructured":"Aguiar LM, et al: Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization. Clinics (Sao Paulo). 2008, 63 (5): 637-644. 10.1590\/S1807-59322008000500012.","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"3978_CR20","first-page":"291","volume":"111","author":"J Klimiuk","year":"2004","unstructured":"Klimiuk J, et al: Lymphocyte and lymphocyte subsets in pleural fluid--comparison of malignant and non-malignant disorders. Pol Arch Med Wewn. 2004, 111 (3): 291-296.","journal-title":"Pol Arch Med Wewn"},{"issue":"10","key":"3978_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1164\/rccm.200511-1789OC","volume":"173","author":"A Scherpereel","year":"2006","unstructured":"Scherpereel A, et al: Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med. 2006, 173 (10): 1155-1160. 10.1164\/rccm.200511-1789OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"3978_CR22","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","volume":"13","author":"BD Grigoriu","year":"2007","unstructured":"Grigoriu BD, et al: Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin Cancer Res. 2007, 13 (10): 2928-2935. 10.1158\/1078-0432.CCR-06-2144.","journal-title":"Clin Cancer Res"},{"key":"3978_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1164\/ajrccm.162.3.9910050","volume":"162","author":"M Noppen","year":"2000","unstructured":"Noppen M, et al: Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med. 2000, 162: 1023-1026. 10.1164\/ajrccm.162.3.9910050.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3978_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2307\/2530051","volume":"38","author":"WJ Conover","year":"1982","unstructured":"Conover WJ, Iman RL: Analysis of covariance using the rank transformation. Biometrics. 1982, 38 (3): 715-724. 10.2307\/2530051.","journal-title":"Biometrics"},{"issue":"3","key":"3978_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","volume":"167","author":"C Baecher-Allan","year":"2001","unstructured":"Baecher-Allan C, et al: CD4 + CD25high Regulatory cells in human peripheral blood. J Immunol. 2001, 167 (3): 1245-1253.","journal-title":"J Immunol"},{"key":"3978_CR26","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.mad.2005.11.001","volume":"127","author":"P Saule","year":"2006","unstructured":"Saule P, et al: Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment. Mech Ageing Dev. 2006, 127: 274-281. 10.1016\/j.mad.2005.11.001.","journal-title":"Mech Ageing Dev"},{"issue":"8","key":"3978_CR27","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1158\/1078-0432.CCR-03-0239","volume":"10","author":"D Atanackovic","year":"2004","unstructured":"Atanackovic D, et al: Characterization of effusion-infiltrating T cells: benign versus malignant effusions. Clin Cancer Res. 2004, 10 (8): 2600-2608. 10.1158\/1078-0432.CCR-03-0239.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3978_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.lungcan.2004.07.046","volume":"47","author":"H Prado-Garcia","year":"2005","unstructured":"Prado-Garcia H, et al: Effector, memory and naive CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients. Lung Cancer. 2005, 47 (3): 361-371. 10.1016\/j.lungcan.2004.07.046.","journal-title":"Lung Cancer"},{"issue":"4","key":"3978_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/(SICI)1097-0320(19970815)30:4<204::AID-CYTO8>3.0.CO;2-J","volume":"30","author":"RY Khalil","year":"1997","unstructured":"Khalil RY, Khalil MM: Flow cytometric study of T-cell subsets in lymphocytic pleural effusions. Cytometry. 1997, 30 (4): 204-205. 10.1002\/(SICI)1097-0320(19970815)30:4<204::AID-CYTO8>3.0.CO;2-J.","journal-title":"Cytometry"},{"issue":"3","key":"3978_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/0962935031000134842","volume":"12","author":"K Szyllo","year":"2003","unstructured":"Szyllo K, et al: The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. Mediators Inflamm. 2003, 12 (3): 131-138. 10.1080\/0962935031000134842.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"3978_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1183\/09031936.93.01040337","volume":"1","author":"G Lucivero","year":"1988","unstructured":"Lucivero G, Pierucci G, Bonomo L: Lymphocyte subsets in peripheral blood and pleural fluid. Eur Respir J. 1988, 1 (4): 337-340.","journal-title":"Eur Respir J"},{"issue":"Pt 4","key":"3978_CR32","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/000456329903600413","volume":"36","author":"ME San Jose","year":"1999","unstructured":"San Jose ME, et al: Lymphocyte populations in tuberculous pleural effusions. Ann Clin Biochem. 1999, 36 (Pt 4): 492-500.","journal-title":"Ann Clin Biochem"},{"issue":"24","key":"3978_CR33","doi-asserted-by":"publisher","first-page":"11752","DOI":"10.1158\/0008-5472.CAN-05-1658","volume":"65","author":"AS Jassar","year":"2005","unstructured":"Jassar AS, et al: Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma. Cancer Res. 2005, 65 (24): 11752-11761. 10.1158\/0008-5472.CAN-05-1658.","journal-title":"Cancer Res"},{"issue":"16","key":"3978_CR34","first-page":"6201","volume":"61","author":"M Odaka","year":"2001","unstructured":"Odaka M, et al: Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity. Cancer Res. 2001, 61 (16): 6201-6212.","journal-title":"Cancer Res"},{"issue":"3","key":"3978_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, et al: Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003, 348 (3): 203-213. 10.1056\/NEJMoa020177.","journal-title":"N Engl J Med"},{"issue":"6832","key":"3978_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/35074122","volume":"410","author":"V Shankaran","year":"2001","unstructured":"Shankaran V, et al: IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001, 410 (6832): 1107-1111. 10.1038\/35074122.","journal-title":"Nature"},{"issue":"1","key":"3978_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1044-5323(02)00127-6","volume":"15","author":"F Balkwill","year":"2003","unstructured":"Balkwill F: Chemokine biology in cancer. Semin Immunol. 2003, 15 (1): 49-55. 10.1016\/S1044-5323(02)00127-6.","journal-title":"Semin Immunol"},{"issue":"2","key":"3978_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000135689","volume":"29","author":"D Atanackovic","year":"2008","unstructured":"Atanackovic D, et al: The local cytokine and chemokine milieu within malignant effusions. Tumour Biol. 2008, 29 (2): 93-104. 10.1159\/000135689.","journal-title":"Tumour Biol"},{"issue":"8","key":"3978_CR39","first-page":"2553","volume":"8","author":"TK Hoffmann","year":"2002","unstructured":"Hoffmann TK, et al: Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res. 2002, 8 (8): 2553-2562.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3978_CR40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1067\/msy.2001.114554","volume":"129","author":"DC Lockhart","year":"2001","unstructured":"Lockhart DC, et al: Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma. Surgery. 2001, 129 (6): 749-756. 10.1067\/msy.2001.114554.","journal-title":"Surgery"},{"issue":"6","key":"3978_CR41","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/BF00730624","volume":"23","author":"M Oka","year":"1993","unstructured":"Oka M, et al: The characterization of peritoneal and pleural exudate cells from malignant effusions. Surg Today. 1993, 23 (6): 500-503. 10.1007\/BF00730624.","journal-title":"Surg Today"},{"issue":"4","key":"3978_CR42","first-page":"347","volume":"40","author":"J Sikora","year":"2002","unstructured":"Sikora J, Zeromski J: Expression of TCR-zeta chain and apoptosis in subpopulations of tumor-associated lymphocytes (TALs) from malignant pleural effusions. Folia Histochem Cytobiol. 2002, 40 (4): 347-351.","journal-title":"Folia Histochem Cytobiol"},{"issue":"7","key":"3978_CR43","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s002620050585","volume":"48","author":"TL Whiteside","year":"1999","unstructured":"Whiteside TL: Signaling defects in T lymphocytes of patients with malignancy. Cancer Immunol Immunother. 1999, 48 (7): 346-352. 10.1007\/s002620050585.","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"3978_CR44","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1164\/rccm.200504-588OC","volume":"172","author":"YQ Chen","year":"2005","unstructured":"Chen YQ, et al: CD4+CD25+ Regulatory T Lymphocytes in Malignant Pleural Effusion. Am J Respir Crit Care. 2005, 172 (11): 1434-1439. 10.1164\/rccm.200504-588OC.","journal-title":"Am J Respir Crit Care"},{"issue":"3","key":"3978_CR45","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4161\/cbt.4.3.1644","volume":"4","author":"P Delong","year":"2005","unstructured":"Delong P, et al: Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma. Cancer Biol Ther. 2005, 4 (3): 342-346. 10.4161\/cbt.4.3.1644.","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"3978_CR46","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s00262-011-1059-6","volume":"60","author":"H Li","year":"2011","unstructured":"Li H, et al: Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin. Cancer Immunol Immunother. 2011, 60 (11): 1587-1596. 10.1007\/s00262-011-1059-6.","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"3978_CR47","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1158\/1078-0432.CCR-08-2641","volume":"15","author":"XJ Qin","year":"2009","unstructured":"Qin XJ, et al: CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res. 2009, 15 (7): 2231-2237. 10.1158\/1078-0432.CCR-08-2641.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3978_CR48","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1183\/09031936.06.00135305","volume":"27","author":"JP Hegmans","year":"2006","unstructured":"Hegmans JP, et al: Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses. Eur Respir J. 2006, 27 (6): 1086-1095. 10.1183\/09031936.06.00135305.","journal-title":"Eur Respir J"},{"issue":"20","key":"3978_CR49","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/jnci\/djn325","volume":"100","author":"GT Stathopoulos","year":"2008","unstructured":"Stathopoulos GT, et al: A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. J Natl Cancer Inst. 2008, 100 (20): 1464-1476. 10.1093\/jnci\/djn325.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3978_CR50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1378\/chest.110.2.433","volume":"110","author":"YM Chen","year":"1996","unstructured":"Chen YM, et al: Elevation of interleukin-10 levels in malignant pleural effusion. Chest. 1996, 110 (2): 433-436. 10.1378\/chest.110.2.433.","journal-title":"Chest"},{"issue":"9","key":"3978_CR51","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ni0902-807","volume":"3","author":"F Colucci","year":"2002","unstructured":"Colucci F, Di Santo JP, Leibson PJ: Natural killer cell activation in mice and men: different triggers for similar weapons?. Nat Immunol. 2002, 3 (9): 807-813. 10.1038\/ni0902-807.","journal-title":"Nat Immunol"},{"issue":"4","key":"3978_CR52","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1182\/blood.V99.4.1273","volume":"99","author":"MJ Loza","year":"2002","unstructured":"Loza MJ, et al: Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood. 2002, 99 (4): 1273-1281. 10.1182\/blood.V99.4.1273.","journal-title":"Blood"},{"issue":"10","key":"3978_CR53","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00262-010-0881-6","volume":"59","author":"N Yamada","year":"2010","unstructured":"Yamada N, et al: CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection. Cancer Immunol Immunother. 2010, 59 (10): 1543-1549. 10.1007\/s00262-010-0881-6.","journal-title":"Cancer Immunol Immunother"},{"key":"3978_CR54","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/1471-2407-12-580","volume":"12","author":"ME Heuvers","year":"2012","unstructured":"Heuvers ME, Aerts JG, Cornelissen R, Groen H, Hoogsteden HC, Hegmans JP: Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment. BMC Cancer. 2012, 12: 580-10.1186\/1471-2407-12-580.","journal-title":"BMC Cancer"},{"key":"3978_CR55","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/S1470-2045(12)70126-2","volume":"13","author":"A Thomas","year":"2012","unstructured":"Thomas A, Hassan R: Immunotherapies for non-small-cell lung cancer and mesothelioma. Lancet Oncol. 2012, 13: e301-e310. 10.1016\/S1470-2045(12)70126-2.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-324\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T20:28:28Z","timestamp":1688329708000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,2]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3978"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-324","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,2]]},"article-number":"324"}}